Related Experiment Video
Updated: Jan 20, 2026

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
Sarah Nersesian1,2, Haley Glazebrook1, Jay Toulany1,2
1Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.
Abstract:
Ovarian cancer (OC) is diagnosed in ~22,000 women in the US each year and kills 14,000 of them. Often, patients are not diagnosed until the later stages of disease, when treatment options are limited, highlighting the urgent need for new and improved therapies for precise cancer control. An individual's immune function and interaction with tumor cells can be prognostic of the response to cancer treatment. Current emerging therapies for OC include immunotherapies, which use antibodies or drive T cell-mediated cancer recognition and elimination. In OC, these have been limited by adverse side effects and tumor characteristics including inter- and intra-tumoral heterogeneity, lack of targetable antigens, loss of tumor human leukocyte antigen expression, high levels of immunosuppressive factors, and insufficient immune cell trafficking. Natural killer (NK) cells may be ideal as primary or collateral effectors to these nascent immunotherapies. NK cells exhibit multiple functions that combat immune escape and tumor relapse: they kill targets and elicit inflammation through antigen-independent pathways and detect loss of HLA as a signal for activation. NK cells are efficient mediators of tumor immune surveillance and control, suppressed by the tumor microenvironment and rescued by immune checkpoint blockade. NK cells are regulated by a variety of activating and inhibitory receptors and already known to be central effectors across an array of existing therapies. In this article, we highlight interactions between NK cells and OC and their potential to change the immunosuppressive tumor microenvironment and participate in durable immune control of OC.
Insights
Ovarian cancer (OC) is a deadly disease often diagnosed late. Natural killer (NK) cells show promise in overcoming OC treatment resistance by enhancing immune surveillance and control within the tumor microenvironment.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Ovarian cancer (OC) has a high mortality rate, with many diagnoses occurring at advanced stages when treatment options are limited.
- Current immunotherapies for OC face challenges due to tumor heterogeneity, lack of targetable antigens, and an immunosuppressive tumor microenvironment.
- Natural killer (NK) cells possess unique mechanisms for tumor cell killing and immune regulation, making them promising candidates for novel OC therapies.
Purpose of the Study:
- To explore the potential of Natural Killer (NK) cells in overcoming treatment resistance in ovarian cancer (OC).
- To highlight the interactions between NK cells and OC and their role in modulating the tumor microenvironment.
- To discuss how NK cells can contribute to durable immune control of OC.
Main Methods:
- Review of existing literature on NK cell biology and function in the context of ovarian cancer.
- Analysis of NK cell interactions with tumor cells and the tumor microenvironment.
- Discussion of NK cell-mediated mechanisms against OC immune escape and relapse.
Main Results:
- NK cells can kill target cells and induce inflammation via antigen-independent pathways.
- NK cells detect the loss of human leukocyte antigen (HLA) as an activation signal, crucial for targeting cancer cells.
- NK cells are suppressed by the tumor microenvironment but can be reactivated by immune checkpoint blockade.
Conclusions:
- NK cells offer a promising therapeutic avenue for ovarian cancer, potentially overcoming limitations of current immunotherapies.
- Harnessing NK cell functions can reshape the immunosuppressive tumor microenvironment, leading to improved cancer control.
- NK cells may play a critical role in achieving durable immune-mediated control of ovarian cancer.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy
Nature and Nurture
What is Natural Selection?
Ovarian Cycle
Chirality in Nature

